89. Cytomegalovirus (CMV) Serostatus Reassessment for Accurate CMV Risk Stratification in CMV Seronegative Kidney Transplant Candidates

Ajmeet Pama-Ghuman(University of California, San Francisco), Abhijit Limaye(University of California, San Francisco), Lakshin Kumar(University of California, San Francisco), Puneet Sood(University of California, San Francisco), Anna Mello(University of California, San Francisco), Garrett R. Roll(City College of San Francisco), Monica Fung(University of California, San Francisco)
Open Forum Infectious Diseases
January 1, 2026
10.1093/ofid/ofaf695.035
Cited by 0

Related Papers

COVID-19 in Immunocompromised Hosts: What We Know So Far
|Clinical Infectious Diseases|2020|568
Integrating host response and unbiased microbe detection for lower respiratory tract infection diagnosis in critically ill adults
|Proceedings of the National Academy of Sciences|2018|434
Epidemiology and Risk Factors for Clostridium difficile Infection in Children
|The Pediatric Infectious Disease Journal|2011|168
Effect of Canakinumab vs Placebo on Survival Without Invasive Mechanical Ventilation in Patients Hospitalized With Severe COVID-19
|JAMA|2021|166
Metagenomic prediction of antimicrobial resistance in critically ill patients with lower respiratory tract infections
|Genome Medicine|2022|120